80
Participants
Start Date
April 1, 2022
Primary Completion Date
August 30, 2023
Study Completion Date
September 30, 2023
TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation
TRELEGY ELLIPTA (fluticasone furoate 100 mcg, umeclidinium 62.5 mcg, and vilanterol 25 mcg inhalation powder)
Baylor Scott & White Health Research Institute, Dallas
Lead Sponsor
Baylor Research Institute
OTHER